Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer

BACKGROUND: Cancer increases the risk of thromboembolic events, especially in people receiving anticoagulation treatments. OBJECTIVES: To compare the efficacy and safety of low molecular weight heparins (LMWHs), direct oral anticoagulants (DOACs), vitamin K antagonists (VKAs), and other anticoagulan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane Database Syst Rev
Hauptverfasser: Kahale, Lara A, Hakoum, Maram B, Tsolakian, Ibrahim G, Alturki, Fadel, Matar, Charbel F, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Yosuico, Victor ED, Schünemann, Holger, Akl, Elie A
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Ltd 2018
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389342/
https://ncbi.nlm.nih.gov/pubmed/29920657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006650.pub5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge